| Dr Shubhang N Mazumdar, MD | |
|
4700 Las Vegas Blvd N, Nellis Afb, NV 89191 | |
| (702) 653-3800 | |
| Not Available |
| Full Name | Dr Shubhang N Mazumdar |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 4700 Las Vegas Blvd N, Nellis Afb, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003887183 | NPI | - | NPPES |
| 000266791B | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 42826 (Arizona) | Secondary |
| 207R00000X | Internal Medicine | 19297 (Georgia) | Primary |
| Entity Name | Wrightsboro Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912386038 PECOS PAC ID: 9638483761 Enrollment ID: O20150804003773 |
News Archive
Today AIDS Healthcare Foundation (AHF) announced that it has banned pharmaceutical sales representatives from Bristol-Myers Squibb (BMS) from calling on AHF's medical providers and staff in its sixteen U.S. healthcare centers. The decision is based on BMS' refusal to lower the price of its key AIDS drug Reyataz for cash-strapped AIDS Drug Assistance Programs.
Consumer Watchdog called on President Obama and Congress in a letter sent today to fix ten problem areas in the new federal health reform law that, if not addressed, will be exploited by health insurers and drug companies looking to charge more for less health care.
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.
A new study into the role of a particular immune cell in the lungs could lead to better treatments for the 5 million people in the UK affected by asthma.
Researchers have studied existing evidence to suggest that people who have had a stroke or a heart attack might benefit from taking blood pressure medications, even if they do not have high blood. They noted that for every 1,000 people taking the drugs in clinical trials, on average 15 fewer died from heart disease than when the patients got dummy treatment. The study however could not explain the cause for this benefit. The study, which was funded by Tulane University and the National Institutes of Health, was published in the March 2 issue of the Journal of the American Medical Association.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shubhang N Mazumdar, MD 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Ph: (702) 653-3800 | Dr Shubhang N Mazumdar, MD 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Ph: (702) 653-3800 |
News Archive
Today AIDS Healthcare Foundation (AHF) announced that it has banned pharmaceutical sales representatives from Bristol-Myers Squibb (BMS) from calling on AHF's medical providers and staff in its sixteen U.S. healthcare centers. The decision is based on BMS' refusal to lower the price of its key AIDS drug Reyataz for cash-strapped AIDS Drug Assistance Programs.
Consumer Watchdog called on President Obama and Congress in a letter sent today to fix ten problem areas in the new federal health reform law that, if not addressed, will be exploited by health insurers and drug companies looking to charge more for less health care.
Cellectis bioresearch, a specialist in genome customization and a subsidiary of Cellectis, today announced the publication of a scientific study describing a novel method, based on meganuclease-driven targeted integration, for the generation of stable cell lines compatible with high throughput screening (HTS).The study demonstrated Cellectis bioresearch's technology to be faster, more reliable and efficient in deriving cell-based assays for HTS studies than classical methods.
A new study into the role of a particular immune cell in the lungs could lead to better treatments for the 5 million people in the UK affected by asthma.
Researchers have studied existing evidence to suggest that people who have had a stroke or a heart attack might benefit from taking blood pressure medications, even if they do not have high blood. They noted that for every 1,000 people taking the drugs in clinical trials, on average 15 fewer died from heart disease than when the patients got dummy treatment. The study however could not explain the cause for this benefit. The study, which was funded by Tulane University and the National Institutes of Health, was published in the March 2 issue of the Journal of the American Medical Association.
› Verified 5 days ago
Dr. Seth Joseph Vanderveer, DO, RHMSUS, CSCS Internal Medicine Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 | |
Dr. Aaron David Lewis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 | |
Derric A. Whiteside, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-3128 | |
John Kim, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-652-2750 | |
Jeremy P Kilburn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-3257 | |
Dr. Robert Brown Woolley, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273 |